Chronic spontaneous urticaria
Showing 26 - 50 of >10,000
Chronic Spontaneous Urticaria Trial in Hungary, United States (barzolvolimab, Matching Placebo)
Recruiting
- Chronic Spontaneous Urticaria
- barzolvolimab
- Matching Placebo
-
Birmingham, Alabama
- +44 more
Dec 8, 2022
Chronic Spontaneous Urticaria Trial (SYN008, Omalizumab for injection)
Not yet recruiting
- Chronic Spontaneous Urticaria
- SYN008
- Omalizumab for injection
- (no location specified)
Jun 22, 2021
Chronic Spontaneous Urticaria Trial in Germany, Poland, United States (LY3454738, Placebo)
Terminated
- Chronic Spontaneous Urticaria
- LY3454738
- Placebo
-
Bakersfield, California
- +24 more
Feb 14, 2022
Chronic Spontaneous Urticaria Trial in Changsha (Recombinant human interleukin-2 (rhIL-2), Control group)
Not yet recruiting
- Chronic Spontaneous Urticaria
- Recombinant human interleukin-2 (rhIL-2)
- Control group
-
Changsha, Hunan, ChinaThe Second Xiangya Hospital of Central South University
May 15, 2021
Chronic Spontaneous Urticaria Trial in Grenoble (association of levocetirizine and tranexamic acid, Levocetirizine only)
Recruiting
- Chronic Spontaneous Urticaria
- association of levocetirizine and tranexamic acid
- Levocetirizine only
-
Grenoble, FranceCHU Grenoble-Alpes
Apr 27, 2021
Chronic Spontaneous Urticaria Trial in Worldwide (rilzabrutinib, )
Recruiting
- Chronic Spontaneous Urticaria
- rilzabrutinib
- placebo
-
Caba, Buenos Aires, Argentina
- +66 more
Jan 20, 2023
Chronic Urticaria Trial in United States (TEV-45779, XOLAIR® Injection)
Recruiting
- Chronic Urticaria
- TEV-45779
- XOLAIR® Injection
-
Bakersfield, California
- +8 more
Dec 16, 2021
Chronic Spontaneous Urticaria Trial in Worldwide (Tezepelumab Dose 1, Tezepelumab Dose 2, Omalizumab)
Recruiting
- Chronic Spontaneous Urticaria
- Tezepelumab Dose 1
- +3 more
-
Birmingham, Alabama
- +81 more
Aug 4, 2022
Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab)
Completed
- Chronic Spontaneous Urticaria
- Ligelizumab
-
Birmingham, Alabama
- +66 more
Oct 7, 2021
Chronic Idiopathic Urticaria Trial (Omalizumab Injection, Xolair Prefilled Syringe)
Not yet recruiting
- Chronic Idiopathic Urticaria
- Omalizumab Injection
- Xolair Prefilled Syringe
- (no location specified)
Mar 7, 2023
Chronic Spontaneous Urticaria Trial in China (Omalizumab, Placebo)
Completed
- Chronic Spontaneous Urticaria
- Omalizumab
- Placebo
-
Beijing, Beijing, China
- +26 more
Nov 3, 2020
Frequency of Parasite Infestation in Chronic Spontaneous
Completed
- Chronic Spontaneous Urticaria
- Parasitic Disease
- Examination of stool samples
-
Basel, SwitzerlandUniversity Hospital Basel
Mar 16, 2020
Chronic Inducible Urticaria Trial in Canada, United States (Oral EP262)
Recruiting
- Chronic Inducible Urticaria
- Oral EP262
-
Tampa, Florida
- +5 more
Sep 18, 2023
Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab, Omalizumab, Placebo)
Completed
- Chronic Spontaneous Urticaria
- Ligelizumab
- +2 more
-
Gilbert, Arizona
- +160 more
Dec 12, 2022
Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa Trial in Canada, Germany, United States
Recruiting
- Atopic Dermatitis
- +5 more
-
Scottsdale, Arizona
- +61 more
Jan 24, 2023
Chronic Spontaneous Urticaria Trial in Istanbul (ShotBlocker®, Placebo group)
Completed
- Chronic Spontaneous Urticaria
- ShotBlocker®
- Placebo group
-
Istanbul, Uskudar, TurkeyUniversity of Health Sciences
Dec 25, 2019
Urticaria Trial in Taichung (Vitamin D, Placebo)
Recruiting
- Urticaria
- Vitamin D
- Placebo
-
Taichung, TaiwanChina Medical University Hospital
Aug 12, 2022
Chronic Cold Urticaria Trial in Leiden (THB001)
Recruiting
- Chronic Cold Urticaria
-
Leiden, NetherlandsCentre for Human Drug Research
Aug 19, 2022
Chronic Urticaria, Anxiety Trial in Kayseri (Positive Psychotherapy Based Counseling)
Not yet recruiting
- Chronic Urticaria
- Anxiety
- Positive Psychotherapy Based Counseling
-
Kayseri, TurkeyErciyes Universty
Aug 22, 2022
Chronic Spontaneous Urticaria Trial in Worldwide (LOU064)
Active, not recruiting
- Chronic Spontaneous Urticaria
-
Litchfield Park, Arizona
- +68 more
Jul 19, 2022